Serum Institute of India may submit its final clinical trial data on AstraZeneca's Covishield by the end of December. If the data is found satisfactory, the government may approve the vaccine by the first week of January.
In the south of England, scientists have identified a "new variant" of the virus that may explain the faster spread of the infection. UK Health Secretary Matt Hancock said that there was no evidence to suggest that it is more dangerous than the existing virus strain.
Tune in to the Coronavirus Essential with Sakshi Batra for more.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
